| Dr Mohammed Wajid Siddiqi, MD | |
|
840 E Hill Ave, Moses Lake, WA 98837-2238 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Dr Mohammed Wajid Siddiqi |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 840 E Hill Ave, Moses Lake, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972610616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD60704467 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohammed Wajid Siddiqi, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Dr Mohammed Wajid Siddiqi, MD 840 E Hill Ave, Moses Lake, WA 98837-2238 Ph: (509) 663-8711 |
News Archive
In an effort to create a uniform and accurate method for determining brain death, the American Academy of Neurology has issued an updated guideline that provides doctors with a step-by-step process for determining brain death in adults. The guideline is published in the June 8, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
In the treatment of large tumors, how effective is adoptive T cell therapy in comparison to drug-based cancer treatment? To answer this question, Dr. Kathleen Anders and Professor Thomas Blankenstein of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and researchers of the Beckman Research Institute of the City of Hope Cancer Center in Duarte, California, USA designed and carried out a study comparing the two methods. Based on a mouse cancer model, the researchers elucidated the mechanisms of the two different treatments.
Cell Signaling Technology, Inc. of Danvers, MA, announced today that it has granted Ventana Medical Systems, Inc., a worldwide non-exclusive license to CST patent rights and proprietary antibody reagents relating to the detection of epidermal growth factor receptor mutations for the field of tissue-based in vitro diagnostic testing.
Researchers find inhaled corticosteroid and long-acting beta agonist (ICS/LABA) combination products are commonly used by patients with mild asthma, despite the lack of evidence or guidelines for such use.
› Verified 3 days ago
Carolanne Lyons, Pediatrics Medicare: Medicare Enrolled Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Miss Carissa Lynn Armstrong, MBBS Pediatrics Medicare: Medicare Enrolled Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Dr. Kriti Narwal, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1550 S Pioneer Way Ste 200, Moses Lake, WA 98837 Phone: 509-793-9787 Fax: 509-764-3263 | |
Karl Christopher Kubo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 615 S Division St, Moses Lake, WA 98837 Phone: 509-766-9450 Fax: 509-766-1954 | |
Karen M Lindberg, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Marta A Beaubien, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-765-0216 | |
Jill A Dudik Bross, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 615 S Division St, Moses Lake, WA 98837 Phone: 509-766-9450 Fax: 509-766-1954 |